Literature DB >> 9300662

Human prion diseases and bovine spongiform encephalopathy (BSE).

J Collinge1.   

Abstract

Prion diseases are transmissible neurodegenerative disorders which affect a range of mammalian species. In humans they can be inherited and sporadic as well as acquired by exposure to human prions. Prions appear to be composed principally of a conformational isomer of host-encoded prion protein and propagate by recruitment of cellular prion protein. Recent evidence argues that prion protein can also encode disease phenotypes by differences in its conformation and glycosylation. Such molecular analysis of prion strains suggests that new variant Creutzfeldt-Jakob disease is caused by BSE exposure. The novel biology of prion propagation may not be unique to these rare degenerative brain diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300662     DOI: 10.1093/hmg/6.10.1699

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

Review 1.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

Review 2.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 3.  Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions.

Authors:  Lyne Jossé; Ricardo Marchante; Jo Zenthon; Tobias von der Haar; Mick F Tuite
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

4.  Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Authors:  Yu-Ting Sui; Kristin M Bullock; Michelle A Erickson; Jing Zhang; W A Banks
Journal:  Peptides       Date:  2014-09-30       Impact factor: 3.750

5.  Vertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model.

Authors:  J Castilla; A Brun; F Díaz-San Segundo; F J Salguero; A Gutiérrez-Adán; B Pintado; M A Ramírez; L del Riego; J M Torres
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.

Authors:  Sandra Müller; Roland Kehm; Michaela Handermann; Nurith J Jakob; Udo Bahr; Björn Schröder; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Prion protein regulates glutamate-dependent lactate transport of astrocytes.

Authors:  Ralf Kleene; Gabriele Loers; Julia Langer; Yveline Frobert; Friedrich Buck; Melitta Schachner
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

9.  Effect of autolysis on the specificity of bovine spongiform encephalopathy rapid tests.

Authors:  Daniela Meloni; Katia Varello; Marzia Pezzolato; Elsa Manzardo; Maria C Cavarretta; Francesco Ingravalle; Maria Caramelli; Elena Bozzetta
Journal:  BMC Res Notes       Date:  2010-07-14

10.  Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231.

Authors:  Alessandro Corsaro; Stefano Thellung; Katia Chiovitti; Valentina Villa; Alessandro Simi; Federica Raggi; Domenico Paludi; Claudio Russo; Antonio Aceto; Tullio Florio
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.